Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 12, 2017
Human Enterocytes as an In Vitro Model for the Evaluation of Intestinal Drug Metabolism: Characterization of Drug-Metabolizing Enzyme Activities of Cryopreserved Human Enterocytes from Twenty-Four DonorsMing-Chih David Ho, Nicholas Ring, Kirsten Amaral, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 11, 2016
Endoplasmic Reticulum Stress Induction and ERK1/2 Activation Contribute to Nefazodone-Induced Toxicity in Hepatic CellsZhen Ren, Si Chen, Jie Zhang, et al.
Journal of Biomolecular Screening|September 21, 2014
High content analysis of an in vitro model for metabolic toxicity: results with the model toxicants 4-aminophenol and cyclophosphamideStephanie D Cole, Janna S Madren-Whalley, Albert P Li, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
Function of uptake transporters for taurocholate and estradiol 17beta-D-glucuronide in cryopreserved human hepatocytesYoshihisa Shitara, Albert P Li, Yukio Kato, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 20, 2015
In situ allicin generation using targeted alliinase delivery for inhibition of MIA PaCa-2 cells via epigenetic changes, oxidative stress and cyclin-dependent kinase inhibitor (CDKI) expressionSagar V Chhabria, Mohammad A Akbarsha, Albert P Li, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 28, 2017
Metabolism-dependent cytotoxicity of citrinin and ochratoxin A alone and in combination as assessed adopting integrated discrete multiple organ co-culture (IdMOC)Loganathan Gayathri, Bagavathy Shanmugam Karthikeyan, Manikkam Rajalakshmi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 4, 2019
Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes)Veera Raghava Choudary Palacharla, Prathyusha Chunduru, Devender Reddy Ajjala, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 2, 2018
Prediction of the Pharmacokinetics of Pravastatin as an OATP Substrate Using Plateable Human Hepatocytes With Human Plasma Data and PBPK ModelingJialin Mao, Utkarsh Doshi, Matthew Wright, et al.
Pageof 9